GPCR photopharmacology

  title={GPCR photopharmacology},
  author={Maria Ricart-Ortega and Joan Font and Amadeu Llebaria},
  journal={Molecular and Cellular Endocrinology},
New technologies for spatial and temporal remote control of G protein-coupled receptors (GPCRs) are necessary to unravel the complexity of GPCR signalling in cells, tissues and living organisms. An effective approach, recently developed, consists on the design of light-operated ligands whereby light-dependent GPCR activity regulation can be achieved. In this context, the use of light provides an advantage as it combines safety, easy delivery, high resolution and it does not interfere with most… 
9 Citations

Topics from this paper

Strategies and considerations of G-protein-coupled receptor photopharmacology.
It is proposed that it is with a full appreciation of the spectrum of pharmacological and pharmacokinetic properties of photoswitchable ligands that research will be better placed to develop ligands with a reduced risk of failure during preclinical progression, to enable photopharmacological approaches to continue to find novel applications.
Mechanistic Insights into Light-Driven Allosteric Control of GPCR Biological Activity.
It is concluded that photoisomerization can take place inside and outside the ligand binding pocket, and this leads to a reversible loss in affinity, in part, due to changes in dissociation rates from the receptor.
Chemical biology of noncanonical G protein-coupled receptor signaling: Toward advanced therapeutics.
The most notable examples of chemical and chemogenetic tools addressing new paradigms in GPCR signaling are highlighted, their promises and limitations are discussed, and future directions are explored.
Photoswitchable antagonists for a precise spatiotemporal control of β2-adrenoceptors.
This work introduces Photoazolol-1-3, a series of photoswitchable azobenzene β2-AR antagonists that can be reversibly controlled with light and provides a molecular rationale for the interaction of the different photoisomers with the receptor.
A toolbox of molecular photoswitches to modulate the CXCR3 chemokine receptor with light
Investigations of positional and substituent effects reveal that halogen substituents on the ortho-position of the outer ring are preferred for conferring partial agonism on the cis form of the ligands, which can aid in new photopharmacology studies of CXCR3 signaling.
Optical Control of Adenosine-Mediated Pain Modulation
The results demonstrate that a photoswitchable adenosine derivative can be used to map the contribution of ARs mediating analgesia in vivo and suggest a major role for A1R and A3R in peripheral-mediated pain sensitization.
"Photo-Rimonabant": Synthesis and Biological Evaluation of Novel Photoswitchable Molecules Derived from Rimonabant Lead to a Highly Selective and Nanomolar "Cis-On" CB1R Antagonist.
It is established that 16a is highly selective for hCB1R over hCB2R, which can be valuable molecular tools for optical modulation of CBRs and better understanding of disorders associated with the endocannabinoid system.
Optical control of muscular nicotinic channels with azocuroniums, photoswitchable azobenzenes bearing two N-methyl-N-carbocyclic quaternary ammonium groups.
These new meta-azocuroniums, which can be modulated ad libitum by light, could be employed as photoswitchable muscle relaxants with fewer side effects for surgical interventions and as tools to better understand the pharmacology of muscle-type nAChRs.
G protein-coupled receptors: structure- and function-based drug discovery
This article intends to provide a comprehensive overview of G protein-coupled receptors to a broader readership that shares some common interests in drug discovery.


A Photoswitchable Dualsteric Ligand Controlling Receptor Efficacy.
BQCAAI proved to be an unprecedented molecular tool; it is the first photoswitchable dualsteric ligand, and its activity can be regulated by light, and it was applied to investigate the time course of several receptor activation processes.
In Vivo Photopharmacology.
An overview of photopharmacology using synthetic switches that have been applied in vivo, i.e., in living cells and organisms is provided.
Emerging Targets in Photopharmacology.
A critical overview of the different pharmacological targets in various organs and a survey of organ systems in the human body that can be addressed in a non-invasive manner are presented.
Precise modulation of neuronal activity with synthetic photoswitchable ligands
This work focuses on systems that contain a synthetic photoswitch, a small molecule that absorbs light to reversibly change its shape that is used in biological applications to incorporate synthetic photoswitches into neuroscience tools.
Specificity and Speed: Tethered Photopharmacology.
Genetically encoded, tethered photopharmacology is a variant of optogenetics and could even play a role in medicine wherever gene therapy is viable if sufficiently selective tethering strategies that operate on wild-type receptors can be developed.
Optical Control of Dopamine Receptors Using a Photoswitchable Tethered Inverse Agonist.
The results indicate that DARs can be chemically engineered for selective remote control by light and provide a template for precision control of Family A GPCRs.
Shedding light on metabotropic glutamate receptors using optogenetics and photopharmacology
Several recently developed optogenetic and photopharmacological solutions for the optical control of mGluRs and their applications are reviewed, from the study of the molecular dynamics of receptor activation to theStudy of their roles in vivo.
Optogenetic approaches for dissecting neuromodulation and GPCR signaling in neural circuits.
This review summarizes four major classes of optical tools to manipulate neuromodulatory GPCR signaling: opsins (including engineered chimeric receptors); photoactivatable proteins; photopharmacology through caging-photoswitchable molecules; fluorescent protein based reporters and biosensors; and technologies to utilize these tools in vitro and in vivo, including Cre dependent viral vector expression and two-photon microscopy.
Optical control of endogenous receptors and cellular excitability using targeted covalent photoswitches
Targeted covalent photoswitches constitute a new class of light-regulated drugs and act as prosthetic molecules that photocontrol the activity of GluK1-expressing neurons, and restore photoresponses in degenerated retina.
Optogenetic pharmacology for control of native neuronal signaling proteins
This work has shown that covalently attaching photoswitch molecules to genetically tagged proteins, the newly emerging methodology of optogenetic pharmacology allows biochemically precise control in targeted subsets of neurons.